Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Integrative Therapies in Multiple Myeloma

NCT06515249

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Bnai Zion Medical Center Haifa, Israel

View Trial Details

Recruiting

Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas

NCT06513234

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

NCT06287398

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
Locations: Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia

View Trial Details

Recruiting

Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

NCT06058858

Conditions: Acute Leukemia, B Cell Lymphoma, Cytomegalovirus Infections, +14 more
Locations: Hopital Robert Debré - APHP Paris, France

Hopital Saint Louis - APHP - Service d'hématologie " Unité Adolescents et jeunes adultes " Paris, France

Hopital Saint-Louis - APHP - Service d'éhamotologie - oncologie Paris, France

View Trial Details

Recruiting

Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients

NCT06505369

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Copenhagen University Hospital (Rigshospitalet) Copenhagen, Denmark

Odense University Hospital Odense, Denmark

Vejle hospital Vejle, Denmark

North Estonia Medical Centre Tallinn, Estonia

View Trial Details

Recruiting

On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma

NCT06503211

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: PersonGen.Anke Cellular Therapeutice Co., Ltd. Hefei, Anhui, China

View Trial Details

Recruiting

Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

NCT06503107

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

NCT06503094

Conditions: B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment

NCT06496308

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Ruijin Hospital Shanghai, China

View Trial Details

Recruiting

A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma

NCT06494371

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions